Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
So Chairman Art Levinson, 61, who succeeded Steve Jobs , 56, who became Apple's first Chairman when he resigned as CEO last August, will have easy sailing. Levinson, CEO of Genentech, will introduce new CEO Tim Cook, 51, as well as the board of...
-
The deal builds on an agreement between the two companies announced last month under which Dako is developing a companion diagnostic for a drug from Amgen for an undisclosed rare but deadly cancer. The company also has similar diagnostic agreements with...
-
One key advantage of Eylea over its main competitors, Genentech’s Lucentis and Avastin, is the formal dosing schedule, which allows dosing every eight weeks following an initial three monthly doses, whereas Lucentis and Avastin are given every month. A...
-
Se pide tanto a los pacientes como a sus facultativos que informen de efectos secundarios negativos de los fármacos con receta a la FDA en el teléfono 1-800-FDA-1088 o en www.fda.gov/medwatch. También pueden informar sobre los efectos secundarios a...
-
Zelboraf and its companion diagnostic have already been approved in the United States, Switzerland, Israel, Brazil, New Zealand and Canada. In the United States, Zelboraf is being co-promoted by Daiichi Sankyo, Inc. and Genentech, a member of the Roche...
-
Patients should call their doctor for medical advice about any side effects. Patients or their caregivers are encouraged to report negative side effects of prescription drugs to the FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. They may also report...
-
Het belangrijkste geneesmiddel van het bedrijf, Zelboraf (vemurafenib/PLX4032), werd in augustus 2011 door de FDA goedgekeurd, en wordt in de V.S. in samenwerking bevorderd door Daiichi Sankyo Inc. en Genentech. Het bedrijf is een portfolio aan het...
-
Gli effetti collaterali possono essere inoltre segnalati a Genentech chiamando il numero 1-888-835-2555. Vemurafenib è una nuova piccola molecola orale che è stata approvata dall’FDA nell’agosto del 2011 ed è commercializzato negli Stati Uniti come...
-
Genentech, which makes the cancer-fighting Avastin right here in Vacaville, is warning doctors that the counterfeit drugs don't contain the key ingredient that makes Avastin effective. It's unclear how many patients have been affected. It should go...
-
Tuesday that it is warning doctors, hospitals and patient groups that a counterfeit version of the medicine has been found in the U.S. Tests of counterfeit vials of Avastin showed that they didn't contain the active ingredient in Roche Holding AG's...
-
Roche's U.S. unit, Genentech, says it doesn't know whether any patients were given the fake drug. The Food and Drug Administration is investigating, and has sent letters to 19 medical practices, mostly in California, but also in Texas and Illinois,...
-
But in the meantime the U.S. system continues to be vulnerable to counterfeits, as highlighted by the Avastin case. ASSOCIATED PRESS This file product image provided by Genentech shows a vial and package for the cancer drug Avastin. “This counterfeit...
-
SAN FRANCISCO, Calif. The San Jose Mercury News reports ( http://bit.ly/Afimj5) that Dionisio Dauz was arrested on Feb. 7 for allegedly stealing the computers from the South San Francisco-based biotech firm. San Mateo County Chief Deputy District...
-
Associated Press | SOUTH SAN FRANCISCO, Calif. Authorities say a janitor is facing charges for allegedly stealing 41 laptop computers from biotech company Genentech. The San Jose Mercury News reports ( http://bit.ly/Afimj5 ) that Dionisio Dauz was...
-
FDA “refrain from publishing a draft guidance document setting forth standards for the ‘similarity’ or ‘sameness’ of biotechnology-derived products. FDA says in its 2012 petition response that Genentech “suggests that any guidance document FDA creates...
About Genentech, Inc.
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
-
AP Photo
This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do...
View Photo » -
AP Photo
In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. Lipitor, the best-selling drug in the history of pharmaceuticals, is the blockbuster that almost wasn't. "There was a lot of...
View Photo » -
AP Photo
In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. "There was a lot of controversy at Warner-Lambert as to whether we should even take our molecule into the clinic" for human...
View Photo » -
Reuters Pictures
Venture capitalist Tom Perkins is interviewed in his office in San Francisco, California September 12, 2011. Perkins, co-founder of Kleiner Perkins and the backer of companies ranging from Genentech to Google, believes much of the venture-capital industry has set itself up for failure. ...
View Photo »
AP Photo
This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do...
View Photo »
